Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution that acts as a stimulant laxative to induce bowel evacuation.
## Primary Indications
* Bowel preparation prior to colonoscopy or surgery.
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, a single 4.5 fl oz (133 mL) dose is administered orally or rectally as directed by the physician, usually divided into two doses (e.g., one evening before and one morning of procedure). Follow specific product instructions and physician's orders carefully.
* **Constipation:** 2.25 fl oz (67 mL) administered rectally as a single dose.
## Pediatric Dosing
* **Constipation:** Dosing for children under 12 years of age is generally **not recommended** without physician supervision due to the risk of electrolyte imbalance. Some sources suggest 1.125 fl oz (33.5 mL) for children 5-11 years, but caution is advised. For children under 5 years, use is generally contraindicated.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, but extreme caution and medical supervision are warranted in patients with compromised kidney function.
## Contraindications
* Congestive heart failure.
* Acute renal failure.
* Colostomy or ileostomy.
* Intestinal obstruction or perforation.
* Congenital megacolon.
* Children under 2 years of age (generally contraindicated).
* Patients with pre-existing electrolyte abnormalities, particularly hyperphosphatemia or hypocalcemia.
* Patients on medications that can affect electrolyte balance (e.g., diuretics, ACE inhibitors).
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation.
* **Serious:**
* **Electrolyte Imbalance:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia. Symptoms can include muscle cramps, weakness, confusion, cardiac arrhythmias, seizures.
* **Dehydration:** Especially with overuse or in susceptible individuals.
* **Renal Damage:** Acute tubular necrosis, interstitial nephritis, especially with repeated use or in patients with underlying renal disease.
* **Colonic Mucosal Injury:** Ulceration, perforation.
## Key Drug Interactions
* **Diuretics:** Increased risk of electrolyte depletion.
* **ACE Inhibitors/ARBs:** Increased risk of hyperkalemia.
* **Calcium Supplements/Vitamin D:** Can exacerbate hyperphosphatemia.
* **Other Laxatives:** Additive effects, increasing risk of dehydration and electrolyte imbalance.
## Monitoring
* **Electrolytes:** Crucial, especially serum phosphate, calcium, sodium, and potassium, particularly in at-risk populations (pediatrics, elderly, renal impairment).
* **Renal function:** BUN, creatinine.
* **Hydration status.**
* **Signs of abdominal pain, distension, or bleeding.**
## Clinical Pearls
* Sodium phosphate enemas should be used for short-term treatment only.
* Ensure adequate oral hydration before and after administration.
* Avoid use in patients with impaired gastric emptying or swallowing difficulties.
* Be aware of the significant risk of hyperphosphatemia and hypocalcemia, particularly in children and patients with renal insufficiency. This risk can be severe and life-threatening.
* For bowel preparation, patients should strictly adhere to dietary restrictions and fluid intake as advised.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the current prescribing information and relevant literature for complete and up-to-date details before making any treatment decisions.
